Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Description

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Conditions

Mild Cognitive Impairment

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.

Towards the Development of a Mobile-health Technology Designed to Encourage the Use of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic

Condition
Mild Cognitive Impairment
Intervention / Treatment

-

Contacts and Locations

Amherst

University of Massachusetts, Amherst, Amherst, Massachusetts, United States, 01003

Newark

The State University of New Jersey, Rutgers, Newark, New Jersey, United States, 07102

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Seventeen points or greater and smaller than twenty-six points on the Montreal Cognitive Assessment (MoCA)
  • * Fifty-five years old and above
  • * Minimal technological literacy (i.e. ability to use a tablet independently)
  • * Having a computer for online videoconferencing-based communication (necessary for online cognitive assessments)
  • * Confounding neurological and psychiatric disorders
  • * History of traumatic brain injury
  • * Clinically known hearing or vision impairment
  • * Severe upper-limb motor impairments that could impact the use of mobile devices
  • * Clinical presentations suggestive of dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, or vascular parkinsonism
  • * Diagnosis of dementia
  • * Major depression
  • * Any significant upper-limb impairment that could affect tablet use
  • * Participation in any other therapist-supervised cognitive training

Ages Eligible for Study

55 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Massachusetts, Amherst,

Sunghoon I Lee, PhD, PRINCIPAL_INVESTIGATOR, University of Massachusetts, Amherst

Study Record Dates

2025-03-31